newsfilter
← Latest News
GlobeNewswire·

Sonnet to Present at the MedInvest Biotech & Pharma Conference

PRINCETON, N.J., Sept. 19, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) (the "Company" or "Sonnet"), a clinical-stage company developing immunotherapeutic drugs targeted